Cargando…
Development of a reverse genetics system for respiratory syncytial virus long strain and an immunogenicity study of the recombinant virus
BACKGROUND: Respiratory Syncytial Virus (RSV) is an important human respiratory pathogen, particularly of infants and older adults, and despite several decades of research and development, no licensed vaccine is available. Studies have confirmed that enhancement of RSV disease does not occur after i...
Autores principales: | Hu, Bing, Jiang, Jiawei, Zhan, Jianbo, Li, Guoming, Jiang, Yongzhong, Guan, Xuhua, Chen, Yuanding, Fang, Zhizheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254404/ https://www.ncbi.nlm.nih.gov/pubmed/25107552 http://dx.doi.org/10.1186/1743-422X-11-142 |
Ejemplares similares
-
A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus
por: Díaz, Fabián E., et al.
Publicado: (2021) -
Influenza and respiratory syncytial virus (RSV) vaccines for infants: Safety, immunogenicity, and efficacy
por: Beeler, Judy A., et al.
Publicado: (2013) -
The immunogenicity and safety of respiratory syncytial virus vaccines in development: A systematic review
por: Shan, Jing, et al.
Publicado: (2021) -
Combinatorial F-G Immunogens as Nipah and Respiratory Syncytial Virus Vaccine Candidates
por: Isaacs, Ariel, et al.
Publicado: (2021) -
Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens
por: Nuñez Castrejon, Ana M., et al.
Publicado: (2022)